4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Complete Androgen Insensitivity Syndrome: From Bench to Bed

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Complete androgen insensitivity syndrome (CAIS) is due to complete resistance to the action of androgens, determining a female phenotype in persons with a 46,XY karyotype and functioning testes. CAIS is caused by inactivating mutations in the androgen receptor gene ( AR). It is organized in eight exons located on the X chromosome. Hundreds of genetic variants in the AR gene have been reported in CAIS. They are distributed throughout the gene with a preponderance located in the ligand-binding domain. CAIS mainly presents as primary amenorrhea in an adolescent female or as a bilateral inguinal/labial hernia containing testes in prepubertal children. Some issues regarding the management of females with CAIS remain poorly standardized (such as the follow-up of intact testes, the timing of gonadal removal and optimal hormone replacement therapy). Basic research will lead to the consideration of new issues to improve long-term well-being (such as bone health, immune and metabolic aspects and cardiovascular risk). An expert multidisciplinary approach is mandatory to increase the long-term quality of life of women with CAIS.

          Related collections

          Most cited references54

          • Record: found
          • Abstract: not found
          • Article: not found

          Androgen receptor defects: historical, clinical, and molecular perspectives.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Estrogen masculinizes neural pathways and sex-specific behaviors.

            Sex hormones are essential for neural circuit development and sex-specific behaviors. Male behaviors require both testosterone and estrogen, but it is unclear how the two hormonal pathways intersect. Circulating testosterone activates the androgen receptor (AR) and is also converted into estrogen in the brain via aromatase. We demonstrate extensive sexual dimorphism in the number and projections of aromatase-expressing neurons. The masculinization of these cells is independent of AR but can be induced in females by either testosterone or estrogen, indicating a role for aromatase in sexual differentiation of these neurons. We provide evidence suggesting that aromatase is also important in activating male-specific aggression and urine marking because these behaviors can be elicited by testosterone in males mutant for AR and in females subjected to neonatal estrogen exposure. Our results suggest that aromatization of testosterone into estrogen is important for the development and activation of neural circuits that control male territorial behaviors.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Integrated Molecular Characterization of Testicular Germ Cell Tumors

              SUMMARY We studied 137 primary testicular germ cell tumors (TGCTs) using high-dimensional assays of genomic, epigenomic, transcriptomic, and proteomic features. These tumors exhibited high aneuploidy and a paucity of somatic mutations. Somatic mutation of only three genes achieved significance—KIT, KRAS, and NRAS—exclusively in samples with seminoma components. Integrated analyses identified distinct molecular patterns that characterized the major recognized histologic subtypes of TGCT: seminoma, embryonal carcinoma, yolk sac tumor, and teratoma. Striking differences in global DNA methylation and microRNA expression between histology subtypes highlight a likely role of epigenomic processes in determining histologic fates in TGCTs. We also identified a subset of pure seminomas defined by KIT mutations, increased immune infiltration, globally demethylated DNA, and decreased KRAS copy number. We report potential biomarkers for risk stratification, such as miRNA specifically expressed in teratoma, and others with molecular diagnostic potential, such as CpH (CpA/CpC/CpT) methylation identifying embryonal carcinomas.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                27 January 2021
                February 2021
                : 22
                : 3
                : 1264
                Affiliations
                [1 ]Pediatric and Adolescent Endocrinology, Division of Paediatrics, Azienda Ospedaliero-Universitaria Pisana, 56126 Pisa, Italy; nina.tyutyusheva@ 123456gmail.com (N.T.); g.baroncelli@ 123456med.unipi.it (G.I.B.); sofia.delios@ 123456gmail.com (S.D.); diego.peroni@ 123456unipi.it (D.P.)
                [2 ]Gynecology and Human Reproduction Physiopathology Unit, IRCCS Policlinico di Sant’Orsola, DIMEC, University of Bologna, 40138 Bologna, Italy; mancini.ilaria89@ 123456gmail.com (I.M.); cristina.meriggiola@ 123456unibo.it (M.C.M.)
                Author notes
                [* ]Correspondence: s.bertelloni@ 123456ao-pisa.toscana.it ; Tel.: +39-050-992743; Fax: +39-050-992641
                Author information
                https://orcid.org/0000-0002-6285-8382
                https://orcid.org/0000-0002-0234-1373
                https://orcid.org/0000-0003-0061-9834
                https://orcid.org/0000-0003-1264-3284
                Article
                ijms-22-01264
                10.3390/ijms22031264
                7865707
                33514065
                6d4b6f03-6a6d-4a9b-b5c6-08e0a4000e41
                © 2021 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 09 December 2020
                : 22 January 2021
                Categories
                Review

                Molecular biology
                complete androgen insensitivity syndrome,androgen receptor,ar gene,gonadal neoplasia,gonadal removal,hormonal substitutive therapy,bone health

                Comments

                Comment on this article